94 related articles for article (PubMed ID: 9127830)
21. Effects of fluoxetine and dothiepin on 24-hour activity in depressed patients.
Stanley N; Fairweather DB; Hindmarch I
Neuropsychobiology; 1999; 39(1):44-8. PubMed ID: 9892859
[TBL] [Abstract][Full Text] [Related]
22. The effect of fluoxetine on sleep EEG in childhood depression: a preliminary report.
Armitage R; Emslie G; Rintelmann J
Neuropsychopharmacology; 1997 Oct; 17(4):241-5. PubMed ID: 9326748
[TBL] [Abstract][Full Text] [Related]
23. Complex movement disorders induced by fluoxetine.
Bharucha KJ; Sethi KD
Mov Disord; 1996 May; 11(3):324-6. PubMed ID: 8723152
[TBL] [Abstract][Full Text] [Related]
24. Predictors of response to amine-specific antidepressants.
Burns RA; Lock T; Edwards DR; Katona CL; Harrison DA; Robertson MM; Nairac B; Abou-Saleh MT
J Affect Disord; 1995 Dec; 35(3):97-106. PubMed ID: 8749837
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
26. Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine.
Faramarzi M; Alipor A; Esmaelzadeh S; Kheirkhah F; Poladi K; Pash H
J Affect Disord; 2008 May; 108(1-2):159-64. PubMed ID: 17936366
[TBL] [Abstract][Full Text] [Related]
27. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
Diaz A; Fouilloux C; Ortiz S
Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
[No Abstract] [Full Text] [Related]
28. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
Tollefson GD; Sayler ME
Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine.
Dittmann RW; Linden M; Osterheider M; Schaaf B; Ohnmacht U; Weber HJ
Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):28-34. PubMed ID: 9035225
[TBL] [Abstract][Full Text] [Related]
30. A toxic reaction from combining fluoxetine and phentermine.
Bostwick JM; Brown TM
J Clin Psychopharmacol; 1996 Apr; 16(2):189-90. PubMed ID: 8690835
[No Abstract] [Full Text] [Related]
31. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
Ko HC; Lu RB; Shiah IS; Hwang CC
Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
[TBL] [Abstract][Full Text] [Related]
32. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
[TBL] [Abstract][Full Text] [Related]
33. Fluoxetine-induced SIADH: most likely in the elderly?
Burke D; Franker S
Aust N Z J Psychiatry; 1996 Apr; 30(2):299-301. PubMed ID: 8811278
[No Abstract] [Full Text] [Related]
34. Fluoxetine and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
Burke D; Fanker S
Aust N Z J Psychiatry; 1996 Apr; 30(2):295-8. PubMed ID: 8811276
[TBL] [Abstract][Full Text] [Related]
35. Treatment of social phobia with fluoxetine.
Perugi G; Nassini S; Lenzi M; Simonini E; Cassano GB; McNair DM
Anxiety; 1994-1995; 1(6):282-6. PubMed ID: 9160588
[No Abstract] [Full Text] [Related]
36. Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.
De Nayer A; Geerts S; Ruelens L; Schittecatte M; De Bleeker E; Van Eeckhoutte I; Evrard JL; Linkowski P; Fossion P; Leyman S; Mignon A
Int J Neuropsychopharmacol; 2002 Jun; 5(2):115-20. PubMed ID: 12135535
[TBL] [Abstract][Full Text] [Related]
37. Fluoxetine once every third day in the treatment of major depressive disorder.
Tural U; Onder E
Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
[TBL] [Abstract][Full Text] [Related]
38. The measurement of retardation in depression.
Dantchev N; Widlöcher DJ
J Clin Psychiatry; 1998; 59 Suppl 14():19-25. PubMed ID: 9818627
[TBL] [Abstract][Full Text] [Related]
39. A Case of Caffeine Intolerance With Long-Term Use of Fluoxetine.
Jamal F; Durgam A; Aickareth G; Bajaj R; Mathews M
Prim Care Companion CNS Disord; 2017 Jun; 19(3):. PubMed ID: 28590600
[No Abstract] [Full Text] [Related]
40. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
